Skip to main content

TTC17 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86022

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-86022-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of human TTC17. Peptide sequence: MRQEATVNYLKELEKQLVAQKIHIEENEDRDTGLEQRHNKEDPDCIKAKV The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for TTC17 Antibody

Western Blot: TTC17 Antibody [NBP2-86022]

Western Blot: TTC17 Antibody [NBP2-86022]

Western Blot: TTC17 Antibody [NBP2-86022] - Host: Rabbit. Target Name: TTC17. Sample Tissue: Human RPMI 8226 Whole Cell lysates. Antibody Dilution: 1ug/ml

Applications for TTC17 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: TTC17

Alternate Names

DKFZp686D20222, FLJ10890, FLJ13099, FLJ23673, tetratricopeptide repeat domain 17, tetratricopeptide repeat protein 17, TPR repeat protein 17

Gene Symbol

TTC17

Additional TTC17 Products

Product Documents for TTC17 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for TTC17 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...